Age Does Not Predict Breast Cancer Outcome
- 1 May 1994
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 129 (5) , 483-488
- https://doi.org/10.1001/archsurg.1994.01420290029004
Abstract
Objective: To determine whether age is a prognostic factor of breast cancer and should be used to make treatment recommendations, because younger patients are considered to have a poorer prognosis compared with that of older patients and, thus, often receive more aggressive therapy. Design: A large group of patients with operable breast cancer, all of whom were followed up prospectively as part of two multicenter trials. Setting: Case Western Reserve University, Cleveland, Ohio, was the primary hospital and study center, with 12 participating regional institutions. Patients: All 1353 patients underwent uniform local-regional therapy that consisted of a modified radical mastectomy. Patients who were node negative were followed up, and patients who were node positive received systemic chemoendocrine therapy. Main Outcome Measures: Patients were followed up at regular intervals for either recurrence or death. Results: Patients ranged in age from 22 to 75 years with a median age of 56 years. Younger patients had more estrogen receptor—negative tumors (P<.0001) and a greater number of positive lymph nodes (P<.0001). Of the 241 black patients in the study, a greater percentage were younger compared with white patients (P<.0001). Age was considered in a Cox's multivariate model, together with nodes, tumor diameter, estrogen receptor content, and race. Age was not a significant predictor of either disease-free (P=.33) or overall (P=.30) survival. Using mixture models with covariates, the estimated average hazards (where λ indicates the force of mortality) of breast cancer deaths per year were similar (P, not significant) for patients 45 years old or younger (λ=0.061), older than 45 years but 65 years old or younger (λ=0.052), and older than 65 years (λ=0.061). Conclusions: In conclusion, younger patients as a group have more aggressive and advanced breast cancer at presentation compared with older patients. Considered in a multivariate model, together with other variables, age does not provide independent prognostic information and should not be used alone for management decisions. (Arch Surg. 1994;129:483-488)Keywords
This publication has 13 references indexed in Scilit:
- Breast cancer imaging in women aged 35 years and underClinical Radiology, 2016
- Application of the theory of finite mixtures for the estimation of ‘cure’ rates of treated cancer patientsStatistics in Medicine, 1990
- Treatment of breast cancer in women older than 70 yearsJournal of Surgical Oncology, 1989
- Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survivalCancer, 1989
- Management of elderly patients with primary breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of NorwayCancer, 1984
- Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years.BMJ, 1983
- Cell proliferation and its relationship to clinical features and relapse in breast cancersCancer, 1981
- Carcinoma of the breast in women under 30 years of age.A clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958–1968Cancer, 1977
- Curability of patients with invasive breast carcinoma based on a 30‐year studyWorld Journal of Surgery, 1977